Ascendis Pharma is a biopharmaceutical company based in Copenhagen, Denmark, that develops long-acting medicines by attaching a drug to a carrier molecule so it releases slowly in the body. Its products treat hormone-related conditions, including growth hormone deficiency in children and low parathyroid hormone in adults. The company serves patients and healthcare providers through specialty medicine markets, and it also runs a commercial operation alongside its research and development work.
Ascendis Pharma A/S is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code A1SN34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #545 of 1455 on the B3 Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendFair
67/100
Mixed trend against its averages.
See the numbers →
Above 200-day average9.7%
From 52-week high-6.0%
MomentumFair
52/100
Typical recent returns for this exchange.
See the numbers →
3-month return-4.1%
6-month return16.2%
12-month, skipping last month8.1%
Stability (higher is calmer)Strong
72/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)31.7%
Worst drawdown, 1 year (smaller is calmer)-19.5%
LiquidityWeak
19/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.00M BRL
Zero-volume days70.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 70.00 – 94.05Daily closes, split-adjusted
Signals
50-day average83.81
200-day average80.58
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.34
Technical summary
Daily
Bullish
11 bullish · 0 neutral · 5 bearish
Weekly
Strongly bullish
9 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
77.72
Bullish
EMA 10
79.31
Bullish
SMA 20
77.35
Bullish
EMA 20
79.51
Bullish
SMA 50
83.81
Bullish
EMA 50
82.16
Bullish
SMA 100
84.80
Bullish
EMA 100
82.70
Bullish
SMA 200
80.58
Bullish
EMA 200
80.03
Bullish
Oscillators (daily)
RSI (14)
73.76
Bearish
MACD (12, 26)
-1.06
Bearish
Momentum (12)
14.39
Bullish
Stochastic %K (14)
98.14
Bearish
Williams %R (14)
-1.86
Bearish
CCI (20)
513.4
Bearish
Pivot points (classic, last session)
S3
88.08
S2
88.24
S1
88.32
Pivot
88.48
R1
88.56
R2
88.72
R3
88.80
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
